From: What initiates chemical intolerance? Findings from a large population-based survey of U.S. adults
 | Model 1 | Model 2 | Model 3 | Model 4 | Model 5 |
---|---|---|---|---|---|
 | Odds ratio (95% CI) | Odds ratio (95% CI) | Odds ratio (95% CI) | Odds ratio (95% CI) | Odds ratio (95% CI) |
Number of initiating events | 2.9 (2.5–3.4) | – | – |  |  |
Number of antibiotic exposures | – | 1.8 (1.7–1.9) | – |  |  |
Female | 2.3 (1.9–2.8) | 2.0 (1.7–2.4) | 2.3 (1.9–2.8) | 2.1 (1.8–2.4) | 2.1 (1.7–2.6) |
Age > 60 | 0.51 (0.4–0.6) | 0.52 (0.4–0.6) | 0.48 (0.38–0.61) | 0.51 (0.42–0.62) | 0.55 (0.43–0.70) |
Household income | 0.93 (0.90–0.96) | 0.93 (0.90–0.95) | 0.93 (0.90–0.96) | 0.92 (0.90–0.95) | 0.93 (0.90 –0.97) |
Implants | – | – | 3.6 (1.2–10.5) | – | 2.9 (0.9–8.5)ns |
Pesticides | – | – | 5.5 (3.5–8.6) | – | 4.8 (3.1–7.5) |
Combustion products | – | – | 2.7 (1.5–4.6) | – | 2.3 (1.3–4.0) |
Mold | – | – | 2.9 (2.1–4.0) | – | 2.3 (1.7–3.3) |
Surgical/medical procedure | – | – | 2.2 (1.6–3.1) | – | 1.9 (1.3–2.6) |
New construction | – | – | 2.3 (1.6–3.3) | – | 2.2 (1.5–3.2) |
Prostate | – | – | – | 2.3 (1.1–4.9) | 1.6 (0.6–4.5)ns |
Skin | – | – | – | 3.0 (2.1–4.3) | 1.7 (1.2–2.6) |
Tonsils | – | – | – | 1.9 (1.4–2.6) | 1.6 (1.1–2.4) |
Gastrointestinal | – | – | – | 2.4(1.7–3.2) | 1.9 (1.3–2.9) |
Sinus | – | – | – | 2.2 (1.8–2.7) | 1.8 (1.4–2.4) |
Wound | – | – | – | 2.2 (1.6–3.0) | 1.8 (1.2–2.7) |
Fungal | – | – | – | 1.5 (1.1–2.2) | 1.1 (0.7–1.7)ns |
Pneumonia | – | – | – | 1.7 (1.4–2.2) | 1.5 (1.1–2.0) |
Ear | – | – | – | 1.5 (1.2–1.8) | 1.2 (0.9–1.5)ns |
Dental | – | – | – | 1.5 (1.2–1.9) | 1.4 (1.1–1.9) |
Vaginal | – | – | – | 0.99 (0.57–1.7)ns | 0.90 (0.5–1.8)ns |
Urinary tract | – | – | – | 1.5(1.2–1.9) | 1.7 (1.2–2.3) |